Recent progress of palmitoyl transferase DHHC3 as a novel antitumor target

Papers of special note have been highlighted as: • of interest

References

• 1. Jin J, Zhi X, Wang X, Meng D. Protein palmitoylation and its pathophysiological relevance. J. Cell Physiol. 236(5), 3220–3233 (2021). • Describes the pathological properties of protein palmitoylation in detail.
  Medline CASGoogle Scholar
• 2. Rocks O, Gerauer M, Vartak N et al. The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins. Cell 141(3), 458–471 (2010).
  Medline CASGoogle Scholar
• 3. Lemonidis K, Werno MW, Greaves J et al. The zDHHC family of S-acyltransferases. Biochem. Soc. Trans. 43(2), 217–221 (2015).
  Medline CASGoogle Scholar
• 4. Fernández-Hernando C, Fukata M, Bernatchez PN et al. Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase. J. Cell Biol. 174(3), 369–377 (2006).
  Medline CASGoogle Scholar
• 5. Lemonidis K, Gorleku OA, Sanchez-Perez MC, Grefen C, Chamberlain LH. The Golgi S-acylation machinery comprises zDHHC enzymes with major differences in substrate affinity and S-acylation activity. Mol. Biol. Cell 25(24), 3870–3883 (2014).
  MedlineGoogle Scholar
• 6. Greaves J, Chamberlain LH. Palmitoylation-dependent protein sorting. J. Cell Biol. 176(3), 249–254 (2007).
  Medline CASGoogle Scholar
• 7. Uemura T, Mori H, Mishina M. Isolation and characterization of Golgi apparatus-specific GODZ with the DHHC zinc finger domain. Biochem. Biophys. Res. Commun. 296(2), 492–496 (2002).
  Medline CASGoogle Scholar
• 8. Keller CA, Yuan X, Panzanelli P et al. The gamma2 subunit of GABA(A) receptors is a substrate for palmitoylation by GODZ. J. Neurosci. 24(26), 5881–5891 (2004).
  Medline CASGoogle Scholar
• 9. Rathenberg J, Kittler JT, Moss SJ. Palmitoylation regulates the clustering and cell surface stability of GABAA receptors. Mol. Cell Neurosci. 26(2), 251–257 (2004).
  Medline CASGoogle Scholar
• 10. Hayashi T, Rumbaugh G, Huganir RL. Differential regulation of AMPA receptor subunit trafficking by palmitoylation of two distinct sites. Neuron 47(5), 709–723 (2005).
  Medline CASGoogle Scholar
• 11. Fang C, Deng L, Keller CA et al. GODZ-mediated palmitoylation of GABA(A) receptors is required for normal assembly and function of GABAergic inhibitory synapses. J. Neurosci. 26(49), 12758–12768 (2006).
  Medline CASGoogle Scholar
• 12. Fukata M, Fukata Y, Adesnik H, Nicoll RA, Bredt DS. Identification of PSD-95 palmitoylating enzymes. Neuron 44(6), 987–996 (2004).
  Medline CASGoogle Scholar
• 13. Chen ZW, Olsen RW. GABAA receptor associated proteins: a key factor regulating GABAA receptor function. J. Neurochem. 100(2), 279–294 (2007).
  Medline CASGoogle Scholar
• 14. Kanaani J, Diacovo MJ, El-Husseini Ael D, Bredt DS, Baekkeskov S. Palmitoylation controls trafficking of GAD65 from Golgi membranes to axon-specific endosomes and a Rab5a-dependent pathway to presynaptic clusters. J. Cell Sci. 117(Pt 10), 2001–2013 (2004).
  Medline CASGoogle Scholar
• 15. El-Husseini AE, Craven SE, Chetkovich DM et al. Dual palmitoylation of PSD-95 mediates its vesiculotubular sorting, postsynaptic targeting, and ion channel clustering. J. Cell Biol. 148(1), 159–172 (2000).
  Medline CASGoogle Scholar
• 16. Sharma C, Wang HX, Li Q et al. Protein acyltransferase DHHC3 regulates breast tumor growth, oxidative stress, and senescence. Cancer Res. 77(24), 6880–6890 (2017). • Shows elevated DHHC3 expression correlating with reduced survival in multiple human cancers.
  Medline CASGoogle Scholar
• 17. Lukk M, Kapushesky M, Nikkilä J et al. A global map of human gene expression. Nat. Biotechnol. 28(4), 322–324 (2010).
  Medline CASGoogle Scholar
• 18. Zhan F, Barlogie B, Arzoumanian V et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 109(4), 1692–1700 (2007).
  Medline CASGoogle Scholar
• 19. Sabates-Bellver J, Van Der Flier LG, De Palo M et al. Transcriptome profile of human colorectal adenomas. Mol. Cancer Res. 5(12), 1263–1275 (2007).
  Medline CASGoogle Scholar
• 20. Maia S, Haining WN, Ansén S et al. Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia. Cancer Res. 65(21), 10050–10058 (2005).
  Medline CASGoogle Scholar
• 21. Shai R, Shi T, Kremen TJ et al. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 22(31), 4918–4923 (2003).
  Medline CASGoogle Scholar
• 22. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J. Clin. Oncol. 24(5), 778–789 (2006).
  Medline CASGoogle Scholar
• 23. Finak G, Bertos N, Pepin F et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 14(5), 518–527 (2008).
  Medline CASGoogle Scholar
• 24. Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, Van Kessel AG, Kovacs G. High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer 9, 152 (2009).
  MedlineGoogle Scholar
• 25. Pei H, Li L, Fridley BL et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16(3), 259–266 (2009).
  Medline CASGoogle Scholar
• 26. Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB, Lowe AW. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 131(3), 925–933 (2006).
  Medline CASGoogle Scholar
• 27. Chamberlain LH, Shipston MJ. The physiology of protein S-acylation. Physiol. Rev. 95(2), 341–376 (2015).
  Medline CASGoogle Scholar
• 28. Jiang H, Zhang X, Chen X, Aramsangtienchai P, Tong Z, Lin H. Protein lipidation: occurrence, mechanisms, biological functions, and enabling technologies. Chem. Rev. 118(3), 919–988 (2018).
  Medline CASGoogle Scholar
• 29. Holland SM, Collura KM, Ketschek A et al. Palmitoylation controls DLK localization, interactions and activity to ensure effective axonal injury signaling. Proc. Natl Acad. Sci. USA 113(3), 763–768 (2016).
  Medline CASGoogle Scholar
• 30. Zhang MM, Wu PY, Kelly FD, Nurse P, Hang HC. Quantitative control of protein S-palmitoylation regulates meiotic entry in fission yeast. PLoS Biol. 11(7), e1001597 (2013).
  Medline CASGoogle Scholar
• 31. Hilgemann DW, Fine M, Linder ME, Jennings BC, Lin MJ. Massive endocytosis triggered by surface membrane palmitoylation under mitochondrial control in BHK fibroblasts. Elife 2(213), 3096–3105 (2013).
  Google Scholar
• 32. Lin DTS, Davis NG, Conibear E. Targeting the ras palmitoylation/depalmitoylation cycle in cancer. Biochem. Soc. Trans. 45(4), 913–921 (2017).
  Medline CASGoogle Scholar
• 33. Sharma C, Rabinovitz I, Hemler ME. Palmitoylation by DHHC3 is critical for the function, expression, and stability of integrin α6β4. Cell. Mol. Life Sci. 69(13), 2233–2244 (2012).
  Medline CASGoogle Scholar
• 34. Tsutsumi R, Fukata Y, Noritake J, Iwanaga T, Perez F, Fukata M. Identification of G protein alpha subunit-palmitoylating enzyme. Mol. Cell. Biol. 29(2), 435–447 (2009).
  Medline CASGoogle Scholar
• 35. Wang J, Xie Y, Wolff DW, Abel PW, Tu Y. DHHC protein-dependent palmitoylation protects regulator of G-protein signaling 4 from proteasome degradation. FEBS Lett. 584(22), 4570–4574 (2010).
  Medline CASGoogle Scholar
• 36. Lu D, Sun HQ, Wang H et al. Phosphatidylinositol 4-kinase IIα is palmitoylated by Golgi-localized palmitoyltransferases in cholesterol-dependent manner. J. Biol. Chem. 287(26), 21856–21865 (2012).
  Medline CASGoogle Scholar
• 37. Sharma C, Yang W, Steen H, Freeman MR, Hemler ME. Antioxidant functions of DHHC3 suppress anti-cancer drug activities. Cell. Mol. Life Sci. 78(5), 2341–2353 (2021). • Describes the relationship between DHHC3 and oxidative stress in detail.
  Medline CASGoogle Scholar
• 38. Yao H, Lan J, Li C et al. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat. Biomed. Eng. 3(4), 306–317 (2019). • Describes the relationship between DHHC3 and immune evasion in detail.
  Medline CASGoogle Scholar
• 39. Lipscomb EA, Mercurio AM. Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression. Cancer Met. Rev. 24(3), 413–423 (2005).
  Medline CASGoogle Scholar
• 40. Stipp CS. Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Rev. Mol. Med. 12(15), e3 (2010).
  MedlineGoogle Scholar
• 41. Nikolopoulos SN, Blaikie P, Yoshioka T, Guo W, Giancotti FG. Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell 6(5), 471–483 (2004).
  Medline CASGoogle Scholar
• 42. Yang XH, Flores LM, Li Q et al. Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res. 70(6), 2256–2263 (2010).
  Medline CASGoogle Scholar
• 43. Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, Hemler ME. Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J. Cell Biol. 167(6), 1231–1240 (2004).
  Medline CASGoogle Scholar
• 44. Gagnoux-Palacios L, Dans M, Van't Hof W et al. Compartmentalization of integrin alpha6beta4 signaling in lipid rafts. J. Cell Biol. 162(7), 1189–1196 (2003).
  Medline CASGoogle Scholar
• 45. Coleman DT, Soung YH, Surh YJ, Cardelli JA, Chung J. Curcumin prevents palmitoylation of integrin β4 in breast cancer cells. PLoS ONE 10(5), e0125399 (2015).
  MedlineGoogle Scholar
• 46. Prior IA, Harding A, Yan J, Sluimer J, Parton RG, Hancock JF. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat. Cell. Biol. 3(4), 368–375 (2001).
  Medline CASGoogle Scholar
• 47. Cifelli C, Rose RA, Zhang H et al. RGS4 regulates parasympathetic signaling and heart rate control in the sinoatrial node. Circ. Res. 103(5), 527–535 (2008).
  Medline CASGoogle Scholar
• 48. Hooks SB, Martemyanov K, Zachariou V. A role of RGS proteins in drug addiction. Biochem. Pharmacol. 75(1), 76–84 (2008).
  Medline CASGoogle Scholar
• 49. Hurst JH, Hooks SB. Regulator of G-protein signaling (RGS) proteins in cancer biology. Biochem. Pharmacol. 78(10), 1289–1297 (2009).
  Medline CASGoogle Scholar
• 50. Graham TR, Burd CG. Coordination of Golgi functions by phosphatidylinositol 4-kinases. Trends. Cell Biol. 21(2), 113–121 (2011).
  Medline CASGoogle Scholar
• 51. Santiago-Tirado FH, Legesse-Miller A, Schott D, Bretscher A. PI4P and Rab inputs collaborate in myosin-V-dependent transport of secretory compartments in yeast. Dev. Cell. 20(1), 47–59 (2011).
  Medline CASGoogle Scholar
• 52. Balla A, Kim YJ, Varnai P et al. Maintenance of hormone-sensitive phosphoinositide pools in the plasma membrane requires phosphatidylinositol 4-kinase IIIalpha. Mol. Biol. Cell 19(2), 711–721 (2008).
  Medline CASGoogle Scholar
• 53. Minogue S. The Many Roles of Type II Phosphatidylinositol 4-kinases in membrane trafficking: new tyicks for old dogs. BioEssays 40(2), 1700145 (2018).
  Google Scholar
• 54. Li J, Gao Z, Zhao D et al. PI-273, a substrate-Competitive, specific small-molecule inhibitor of PI4KIIα, inhibits the growth of breast cancer cells. Cancer Res. 77(22), 6253–6266 (2017).
  Medline CASGoogle Scholar
• 55. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug. Discov. 8(7), 579–591 (2009).
  Medline CASGoogle Scholar
• 56. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug. Discov. 12(12), 931–947 (2013).
  Medline CASGoogle Scholar
• 57. Hwang JW, Yao H, Caito S, Sundar IK, Rahman I. Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radic. Biol. Med. 61, 95–110 (2013).
  Medline CASGoogle Scholar
• 58. Mahmood DF, Abderrazak A, El Hadri K, Simmet T, Rouis M. The thioredoxin system as a therapeutic target in human health and disease. Antioxid. Redox. Signal. 19(11), 1266–1303 (2013).
  Medline CASGoogle Scholar
• 59. Pérez-Mancera PA, Young AR, Narita M. Inside and out: the activities of senescence in cancer. Nat. Rev. Cancer 14(8), 547–558 (2014).
  Medline CASGoogle Scholar
• 60. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int. J. Biochem. Cell Biol. 37(5), 961–976 (2005).
  Medline CASGoogle Scholar
• 61. Yang W, Di Vizio D, Kirchner M, Steen H, Freeman MR. Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes. Mol. Cell Proteomics 9(1), 54–70 (2010).
  Medline CASGoogle Scholar
• 62. Lin QH, Zhang KD, Duan HX, Liu MX, Wei WL, Cao Y. ERGIC3, which is regulated by miR-203a, is a potential biomarker for non-small cell lung cancer. Cancer Sci. 106(10), 1463–1473 (2015).
  Medline CASGoogle Scholar
• 63. Wu M, Tu T, Huang Y, Cao Y. Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene. BMC Cancer 13(9), 44–45 (2013).
  Medline CASGoogle Scholar
• 64. Nguyen TL, Schneppenheim J, Rudnik S et al. Functional characterization of the lysosomal membrane protein TMEM192 in mice. Oncotarget 8(27), 43635–43652 (2017).
  MedlineGoogle Scholar
• 65. Burr ML, Sparbier CE, Chan YC et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature 549(7670), 101–105 (2017).
  Medline CASGoogle Scholar
• 66. Handy DE, Loscalzo J. Redox regulation of mitochondrial function. Antioxid. Redox. Signal. 16(11), 1323–1367 (2012).
  Medline CASGoogle Scholar
• 67. Chen Y, Ning J, Cao W et al. Research progress of TXNIP as a tumor suppressor gene participating in the metabolic reprogramming and oxidative stress of cancer cells in various cancers. Front. Oncol. 10, 568574 (2020).
  MedlineGoogle Scholar
• 68. Panieri E, Gogvadze V, Norberg E, Venkatesh R, Orrenius S, Zhivotovsky B. Reactive oxygen species generated in different compartments induce cell death, survival, or senescence. Free Radic. Biol. Med. 57(2), 176–187 (2013).
  Medline CASGoogle Scholar
• 69. Coppé JP, Patil CK, Rodier F et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6(12), 2853–2868 (2008).
  Medline CASGoogle Scholar
• 70. Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci. Transl. Med. 8(328), 328rv4 (2016).
  MedlineGoogle Scholar
• 71. Yang Y, Hsu JM, Sun L et al. Palmitoylation stabilizes PD-L1 to promote breast tumor growth. Cell Res. 29(1), 83–86 (2019).
  MedlineGoogle Scholar
• 72. Li CW, Lim SO, Xia W et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat. Commun. 7, 12632 (2016).
  Medline CASGoogle Scholar
• 73. Linder ME, Deschenes RJ. Palmitoylation: policing protein stability and traffic. Nat. Rev. Mol. Cell Biol. 8(1), 74–84 (2007).
  Medline CASGoogle Scholar
• 74. Mezzadra R, Sun C, Jae LT et al. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature 549(7670), 106–110 (2017).
  Medline CASGoogle Scholar
• 75. Verardi R, Kim JS, Ghirlando R, Banerjee A. Structural basis for substrate recognition by the ankyrin repeat domain of human DHHC17 palmitoyltransferase. Structure 25(9), 1337–1347 (2017).
  Medline CASGoogle Scholar
• 76. Rana MS, Kumar P, Lee CJ, Verardi R, Rajashankar KR, Banerjee A. Fatty acyl recognition and transfer by an integral membrane S-acyltransferase. Science 359(6372), 176 (2018).
  CASGoogle Scholar
• 77. Mitchell DA, Vasudevan A, Linder ME, Deschenes RJ. Protein palmitoylation by a family of DHHC protein S-acyltransferases. J. Lipid Res. 47(6), 1118–1127 (2006).
  Medline CASGoogle Scholar
• 78. Howie J, Reilly L, Fraser NJ et al. Substrate recognition by the cell surface palmitoyl transferase DHHC5. Proc. Natl Acad. Sci. USA 111(49), 17534–17539 (2014).
  Medline CASGoogle Scholar
• 79. Berlow RB, Dyson HJ, Wright PE. Functional advantages of dynamic protein disorder. FEBS Lett. 589(19), 2433–2440 (2015).
  Medline CASGoogle Scholar
• 80. Liu Z, Huang Y. Advantages of proteins being disordered. Protein Sci. 23(5), 539–550 (2014).
  Medline CASGoogle Scholar
• 81. Gottlieb CD, Linder ME. Structure and function of DHHC protein S-acyltransferases. Biochem. Soc. Trans. 45(4), 923–928 (2017). • Explains the structure and function of DHHC protein.
  Medline CASGoogle Scholar
• 82. Gottlieb CD, Zhang S, Linder ME. The cysteine-rich domain of the DHHC3 palmitoyltransferase is palmitoylated and contains tightly bound zinc. J. Biol. Chem. 290(49), 29259–29269 (2015).
  Medline CASGoogle Scholar
• 83. González Montoro A, Quiroga R, Valdez Taubas J. Zinc co-ordination by the DHHC cysteine-rich domain of the palmitoyltransferase Swf1. Biochem. J. 454(3), 427–435 (2013).
  MedlineGoogle Scholar
• 84. Rana MS, Lee CJ, Banerjee A. The molecular mechanism of DHHC protein acyltransferases. Biochem. Soc. Trans. 47(1), 157–167 (2019). • Explains the molecular mechanism of DHHC protein acyltransferases.
  Medline CASGoogle Scholar
• 85. Won SJ, Martin BR. Temporal profiling establishes a dynamic S-palmitoylation cycle. ACS Chem. Biol. 13(6), 1560–1568 (2018).
  Medline CASGoogle Scholar
• 86. Drisdel RC, Manzana E, Green WN. The role of palmitoylation in functional expression of nicotinic alpha7 receptors. J. Neurosci. 24(46), 10502–10510 (2004).
  Medline CASGoogle Scholar
• 87. Valdez-Taubas J, Pelham H. Swf1-dependent palmitoylation of the SNARE Tlg1 prevents its ubiquitination and degradation. EMBO J. 24(14), 2524–2532 (2005).
  Medline CASGoogle Scholar
• 88. Murphy J, Kolandaivelu S. Palmitoylation of progressive rod-cone degeneration (PRCD) regulates protein stability and localization. J. Biol. Chem. 291(44), 23036–23046 (2016).
  Medline CASGoogle Scholar
• 89. Rossin A, Durivault J, Chakhtoura-Feghali T, Lounnas N, Gagnoux-Palacios L, Hueber AO. Fas palmitoylation by the palmitoyl acyltransferase DHHC7 regulates Fas stability. Cell. Death Differ. 22(4), 643–653 (2015).
  Medline CASGoogle Scholar
• 90. Rocks O, Peyker A, Kahms M et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307(5716), 1746–1752 (2005).
  Medline CASGoogle Scholar
• 91. Craven SE, El-Husseini AE, Bredt DS. Synaptic targeting of the postsynaptic density protein PSD-95 mediated by lipid and protein motifs. Neuron 22(3), 497–509 (1999).
  Medline CASGoogle Scholar
• 92. Michaelson D, Ahearn I, Bergo M, Young S, Philips M. Membrane trafficking of heterotrimeric G proteins via the endoplasmic reticulum and Golgi. Mol. Biol. Cell 13(9), 3294–3302 (2002).
  Medline CASGoogle Scholar
• 93. Hayashi T, Thomas GM, Huganir RL. Dual palmitoylation of NR2 subunits regulates NMDA receptor trafficking. Neuron 64(2), 213–226 (2009).
  Medline CASGoogle Scholar
• 94. Yount JS, Moltedo B, Yang YY et al. Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat. Chem. Biol. 6(8), 610–614 (2010).
  Medline CASGoogle Scholar
• 95. Runkle KB, Kharbanda A, Stypulkowski E et al. Inhibition of DHHC20-mediated EGFR palmitoylation creates a dependence on EGFR signaling. Mol. Cell. 62(3), 385–396 (2016).
  Medline CASGoogle Scholar
• 96. Mitchell DA, Mitchell G, Ling Y, Budde C, Deschenes RJ. Mutational analysis of Saccharomyces cerevisiae Erf2 reveals a two-step reaction mechanism for protein palmitoylation by DHHC enzymes. J. Biol. Chem. 285(49), 38104–38114 (2010).
  Medline CASGoogle Scholar
• 97. Jennings BC, Linder ME. DHHC protein S-acyltransferases use similar ping-pong kinetic mechanisms but display different acyl-CoA specificities. J. Biol. Chem. 287(10), 7236–7245 (2012).
  Medline CASGoogle Scholar
• 98. Lobo S, Greentree WK, Linder ME, Deschenes RJ. Identification of a ras palmitoyltransferase in Saccharomyces cerevisiae. J. Biol. Chem. 277(43), 41268–41273 (2002).
  Medline CASGoogle Scholar
• 99. Roth AF, Feng Y, Chen L, Davis NG. The yeast DHHC cysteine-rich domain protein Akr1p is a palmitoyl transferase. J. Cell Biol. 159(1), 23–28 (2002).
  Medline CASGoogle Scholar
• 100. González Montoro A, Chumpen Ramirez S, Valdez Taubas J. The canonical DHHC motif is not absolutely required for the activity of the yeast S-acyltransferases Swf1 and Pfa4. J. Biol. Chem. 290(37), 22448–22459 (2015).
  MedlineGoogle Scholar
• 101. Jennings BC, Nadolski MJ, Ling Y et al. 2-Bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro. J. Lipid Res. 50(2), 233–242 (2009).
  Medline CASGoogle Scholar
• 102. Hamel LD, Lenhart BJ, Mitchell DA et al. Identification of protein palmitoylation inhibitors from a scaffold ranking library. Comb. Chem. High Through. Screen 19(4), 262–274 (2016).
  Medline CASGoogle Scholar
• 103. Moche M, Schneider G, Edwards P, Dehesh K, Lindqvist Y. Structure of the complex between the antibiotic cerulenin and its target, beta-ketoacyl-acyl carrier protein synthase. J. Biol. Chem. 274(10), 6031–6034 (1999).
  Medline CASGoogle Scholar
• 104. Ducker CE, Griffel LK, Smith RA et al. Discovery and characterization of inhibitors of human palmitoyl acyltransferases. Mol. Cancer. Ther. 5(7), 1647–1659 (2006).
  Medline CASGoogle Scholar
• 105. Hamel LD, Lenhart BJ, Mitchell DA, Santos RG, Giulianotti MA, Deschenes RJ. Identification of protein palmitoylation inhibitors from a scaffold ranking library. Comb. Chem. High. T. Scr. 19(4), 262–274 (2016).
  Medline CASGoogle Scholar
• 106. Abrami L, Audagnotto M, Ho S et al. Palmitoylated acyl protein thioesterase APT2 deforms membranes to extract substrate acyl chains. Nat Chem Biol. 17(4), 438–447 (2021).
  Medline CASGoogle Scholar